Increased myofilament Ca sensitivity is a common feature of sarcomeric mutations that cause familial hypertrophic cardiomyopathy (HCM) and the same Ca sensitivity increase has also been described after myocardial infarction (MI). Both diseases are associated with a high risk for ventricular arrhythmia and sudden death, but the mechanisms linking myofilament Ca sensitivity and arrhythmia susceptibility remain poorly understood. This renewal application will investigate the mechanistic link between myofilament Ca sensitivity and triggered arrhythmia. During the last funding cycle, we discovered that two Ca-sensitizing Troponin T (TnT) mutations (I79N, F110I) and the Ca sensitizing compound EMD57033 both significantly increase the Ca binding affinity of the cytosol (i.e., apparent Kd), but have no effect on the maximal cytosolic buffering capacity (i.e., Bmax). These data establish for the first time a direct effect of the TnT mutations on cytosolic Ca buffering properties. The main consequence of the increased myofilament Ca binding affinity at physiological heart rates was an increase in end-diastolic Ca in the cytosol. Surprisingly, and in contrast to previous predictions, Ca content in the sarcoplasmic reticulum (SR) was NOT reduced. Rather, the net effect of increased myofilament Ca binding was the accumulation of Ca in the cytosol during periods of rapid heart rates, which after brief pauses then led to SR Ca overload, action potential (AP) prolongation and early afterdepolarizations. Together with our finding of pause-dependent triggering of serious ventricular arrhythmia both in HCM and post-MI mouse models, these provocative new results have led us to formulate the following hypothesis: Increased myofilament Ca binding affinity is a fundamental defect that causes pause-dependent SR Ca overload and thereby increases triggered arrhythmia susceptibility. Experiments in Aim 1 will test whether our hypothesis can be generalized to other sarcomeric mutations that cause inherited cardiomyopathies (i.e., familial HCM or dilated cardiomyopathy [DCM]).
Aim 2 will determine how increased myofilament Ca binding alters Ca handling and AP regulation in different species.
Aim 3 will test whether increased myofilament Ca binding causes arrhythmia risk in acquired heart disease (i.e., ischemic cardiomyopathy).
Aim 1. To test the hypothesis that sarcomeric mutations that change myofilament Ca sensitivity cause concordant changes in myofilament Ca binding affinity and cytosolic Ca buffering Aim 2. To determine the effect of increased myofilament Ca binding affinity on myocyte Ca homeostasis and action potential regulation in different species Aim 3. To test the hypothesis that increased myofilament Ca binding contributes to triggered arrhythmia after chronic MI

Public Health Relevance

The proposed work will study the causes for certain inherited heart diseases associated with arrhythmia (= irregular heart beats) and a high risk for sudden and premature deaths. The studies will also examine the benefit of new drugs in an animal model, which will provide important information for new drug therapies for patients with inherited arrhythmia disorders.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
2R01HL071670-10
Application #
8653094
Study Section
Special Emphasis Panel (ZRG1-CVRS-Q (02))
Program Officer
Lathrop, David A
Project Start
2003-09-01
Project End
2017-11-30
Budget Start
2013-12-12
Budget End
2014-11-30
Support Year
10
Fiscal Year
2014
Total Cost
$351,938
Indirect Cost
$126,938
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Hwang, Hyun Seok; Nitu, Florentin R; Yang, Yi et al. (2014) Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants. Circ Res 114:1114-24
Gomez-Hurtado, Nieves; Knollmann, Björn C (2014) Calcium in atrial fibrillation - pulling the trigger or not? J Clin Invest 124:4684-6
Faggioni, Michela; Savio-Galimberti, Eleonora; Venkataraman, Raghav et al. (2014) Suppression of spontaneous ca elevations prevents atrial fibrillation in calsequestrin 2-null hearts. Circ Arrhythm Electrophysiol 7:313-20
Yang, Tao; Chun, Young Wook; Stroud, Dina M et al. (2014) Screening for acute IKr block is insufficient to detect torsades de pointes liability: role of late sodium current. Circulation 130:224-34
Roden, Dan M; Knollmann, Björn C (2014) Dantrolene: from better bacon to a treatment for ventricular fibrillation. Circulation 129:834-6
Faggioni, Michela; van der Werf, Christian; Knollmann, Bjorn C (2014) Sinus node dysfunction in catecholaminergic polymorphic ventricular tachycardia: risk factor and potential therapeutic target? Trends Cardiovasc Med 24:273-8
Huke, Sabine; Venkataraman, Raghav; Faggioni, Michela et al. (2013) Focal energy deprivation underlies arrhythmia susceptibility in mice with calcium-sensitized myofilaments. Circ Res 112:1334-44
Venkataraman, Raghav; Baldo, Marcelo Perim; Hwang, Hyun Seok et al. (2013) Myofilament calcium de-sensitization and contractile uncoupling prevent pause-triggered ventricular tachycardia in mouse hearts with chronic myocardial infarction. J Mol Cell Cardiol 60:8-15
Faggioni, Michela; Hwang, Hyun Seok; van der Werf, Christian et al. (2013) Accelerated sinus rhythm prevents catecholaminergic polymorphic ventricular tachycardia in mice and in patients. Circ Res 112:689-97
Sinnecker, Daniel; Goedel, Alexander; Laugwitz, Karl-Ludwig et al. (2013) Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research. Circ Res 112:961-8

Showing the most recent 10 out of 45 publications